| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Division of Clinical Physiology, Department of Medical Laboratory Sciences and Technology, Karolinska Institutet, Huddinge University Hospital, S-141 86 Huddinge, Sweden; and 2 Department of Biochemistry and 3 Molecular Biology Program of Graduate School of Biomedical Sciences, Medical College of Wisconsin, Milwaukee, Wisconsin 53226
AMPD1 genotype, relative fiber type composition, training status, and gender were evaluated as contributing factors to the reported variation in AMP deaminase enzyme activity in healthy skeletal muscle. Multifactorial correlative analyses demonstrate that AMPD1 genotype has the greatest effect on enzyme activity. An AMPD1 mutant allele frequency of 13.7 and a 1.7% incidence of enzyme deficiency was found across 175 healthy subjects. Homozygotes for the AMPD1 normal allele have high enzyme activities, and heterozygotes display intermediate activities. When examined according to genotype, other factors were found to affect variability as follows: AMP deaminase activity in homozygotes for the normal allele exhibits a negative correlation with the relative percentage of type I fibers and training status. Conversely, residual AMP deaminase activity in homozygotes for the mutant allele displays a positive correlation with the relative percentage of type I fibers. Opposing correlations in different homozygous AMPD1 genotypes are likely due to relative fiber-type differences in the expression of AMPD1 and AMPD3 isoforms. Gender also contributes to variation in total skeletal muscle AMP deaminase activity, with normal homozygous and heterozygous women showing only 85-88% of the levels observed in genotype-matched men.
myoadenylate deaminase; isoform; AMP deaminase deficiency; genotype; fiber types
This article has been cited by other articles:
|
|
 |
|
  H. Fischer, M. Esbjornsson, R. L. Sabina, A. Stromberg, M. Peyrard-Janvid, and B. Norman AMP deaminase deficiency is associated with lower sprint cycling performance in healthy subjects J Appl Physiol, July 1, 2007; 103(1): 315 - 322. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R. Hancock, E. Janssen, and R. L. Terjung Skeletal muscle contractile performance and ADP accumulation in adenylate kinase-deficient mice Am J Physiol Cell Physiol, June 1, 2005; 288(6): C1287 - C1297. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. K Kalsi, A. H.Y Yuen, I. M Rybakowska, P. H Johnson, E. Slominska, E. J Birks, K. Kaletha, M. H Yacoub, and R. T Smolenski Decreased cardiac activity of AMP deaminase in subjects with the AMPD1 mutation--A potential mechanism of protection in heart failure Cardiovasc Res, September 1, 2003; 59(3): 678 - 684. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Rico-Sanz, T. Rankinen, D. R. Joanisse, A. S. Leon, J. S. Skinner, J. H. Wilmore, D. C. Rao, and C. Bouchard Associations between cardiorespiratory responses to exercise and the C34T AMPD1 gene polymorphism in the HERITAGE Family study Physiol Genomics, July 7, 2003; 14(2): 161 - 166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Norman, R. L. Sabina, and E. Jansson Regulation of skeletal muscle ATP catabolism by AMPD1 genotype during sprint exercise in asymptomatic subjects J Appl Physiol, July 1, 2001; 91(1): 258 - 264. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
